Position in BLLN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$10,550,321
+$3,515,663 QoQ
Shares Held
87,934
-1.3% QoQ
Ownership
0.186%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 156 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $16,517,996,286 across 38 Diagnostics & Research names. BLLN ranks #30 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
8,382,401 | $4,202,600,564 | |
| 2 | DHR |
Danaher Corp /De/
|
14,280,335 | $2,720,118,210 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
2,562,886 | $1,349,205,704 | |
| 4 | A |
Agilent Technologies, Inc.
|
7,595,644 | $1,008,929,392 | |
| 5 | WAT |
Waters Corp /De/
|
2,636,146 | $988,660,195 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
4,454,134 | $860,627,771 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
612,153 | $782,031,578 | |
| 8 | NTRA |
Natera, Inc.
|
2,750,013 | $746,491,028 |
All Filings in BLLN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,550,321 | 87,934 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $7,034,658 | 89,114 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,713,662 | 82,034 | Shares | Defined | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||